DE69939468D1 - Verfahren um den Erfolg von einem auf in-vitro Maturation (IVM) basierten Verfahren zu vorhersagen - Google Patents

Verfahren um den Erfolg von einem auf in-vitro Maturation (IVM) basierten Verfahren zu vorhersagen

Info

Publication number
DE69939468D1
DE69939468D1 DE69939468T DE69939468T DE69939468D1 DE 69939468 D1 DE69939468 D1 DE 69939468D1 DE 69939468 T DE69939468 T DE 69939468T DE 69939468 T DE69939468 T DE 69939468T DE 69939468 D1 DE69939468 D1 DE 69939468D1
Authority
DE
Germany
Prior art keywords
medium
maturation
heading
ivm
predict
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69939468T
Other languages
English (en)
Inventor
Svend Lindenberg
Anne Lis Mikkelsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medi-Cult AS
Original Assignee
Medi-Cult AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK199900885A external-priority patent/DK199900885A/da
Application filed by Medi-Cult AS filed Critical Medi-Cult AS
Application granted granted Critical
Publication of DE69939468D1 publication Critical patent/DE69939468D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/48—Regulators of apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Developmental Biology & Embryology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
DE69939468T 1998-06-22 1999-06-22 Verfahren um den Erfolg von einem auf in-vitro Maturation (IVM) basierten Verfahren zu vorhersagen Expired - Lifetime DE69939468D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9011598P 1998-06-22 1998-06-22
DK199900885A DK199900885A (da) 1998-06-22 Fremgangsmåde for tildeling af et vilkårligt beløb på en given taletidskortkonto
PCT/DK1999/000344 WO1999067644A1 (en) 1998-06-22 1999-06-22 Assay to indicate the presence of non-fertilisable ova

Publications (1)

Publication Number Publication Date
DE69939468D1 true DE69939468D1 (de) 2008-10-16

Family

ID=26064838

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69939468T Expired - Lifetime DE69939468D1 (de) 1998-06-22 1999-06-22 Verfahren um den Erfolg von einem auf in-vitro Maturation (IVM) basierten Verfahren zu vorhersagen

Country Status (23)

Country Link
US (2) US20010028878A1 (de)
EP (2) EP1088056A1 (de)
JP (1) JP2002519640A (de)
CN (2) CN1161615C (de)
AT (1) ATE407363T1 (de)
AU (2) AU4360599A (de)
BR (1) BR9911470A (de)
CA (2) CA2335793A1 (de)
DE (1) DE69939468D1 (de)
EE (1) EE200000763A (de)
ES (1) ES2313785T3 (de)
HR (1) HRP20000888A2 (de)
HU (1) HUP0103392A2 (de)
ID (1) ID27197A (de)
IL (2) IL140394A0 (de)
IS (1) IS5768A (de)
NO (2) NO20006519L (de)
NZ (1) NZ509451A (de)
PL (1) PL345318A1 (de)
RU (1) RU2227916C2 (de)
SK (1) SK19152000A3 (de)
TR (1) TR200003830T2 (de)
WO (2) WO1999067365A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003076600A2 (en) * 2002-03-08 2003-09-18 Mcgill University In vitro maturation of immature human oocytes
JP2005529609A (ja) * 2002-06-17 2005-10-06 ケベンハウンス・アムツ・シゲフス・ハーレウ 体外受精
US8071375B2 (en) * 2003-11-26 2011-12-06 Merck Serono Sa Use of IL-6-type cytokines for maturation of oocytes
US20070020755A1 (en) * 2005-07-07 2007-01-25 Teresa Woodruff Stage specific follicle maturation systems
CN103275930B (zh) * 2013-06-20 2014-07-09 江苏皓康生物医药科技有限公司 一种卵母细胞体外成熟培养液及其制备方法
US10975353B2 (en) 2014-06-10 2021-04-13 Polybiocept Gmbh Culture medium for cellular immunotherapy
WO2017143412A1 (en) * 2016-02-24 2017-08-31 Universidade Estadual Paulista "Júlioo De Mesquita Filho" - Unesp Follicular system for in vitro oocyte maturation and kit
CN110628705A (zh) * 2019-10-22 2019-12-31 山东畜牧兽医职业学院 一种驴胚胎冲洗液及其应用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614715A (en) * 1982-05-14 1986-09-30 The Board Of Trustees Of The University Of Illinois Predictive test for impending ovulation in mammals
RU2013989C1 (ru) * 1991-08-13 1994-06-15 Борис Васильевич Леонов Способ определения овуляции
GB9217866D0 (en) * 1992-08-21 1992-10-07 Unilever Plc Monitoring method
WO1995016920A1 (en) * 1993-12-16 1995-06-22 Abbott Laboratories Methods and means for determining the female fertile period
GB9410345D0 (en) * 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
GB9603326D0 (en) * 1996-02-16 1996-04-17 Royal Free Hosp School Med Predictive assay
EP0833160B1 (de) * 1996-09-27 2002-02-13 Unilever Plc Überwachungsverfahren
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media

Also Published As

Publication number Publication date
ATE407363T1 (de) 2008-09-15
EE200000763A (et) 2002-06-17
AU4360499A (en) 2000-01-10
CA2335632A1 (en) 1999-12-29
NO20006545D0 (no) 2000-12-21
NZ509451A (en) 2003-03-28
WO1999067365A1 (en) 1999-12-29
ID27197A (id) 2001-03-08
HUP0103392A2 (hu) 2002-01-28
US20010028878A1 (en) 2001-10-11
BR9911470A (pt) 2001-03-20
EP1090300B1 (de) 2008-09-03
JP2002519640A (ja) 2002-07-02
ES2313785T3 (es) 2009-03-01
US20020115211A1 (en) 2002-08-22
IS5768A (is) 2000-12-12
SK19152000A3 (sk) 2001-12-03
IL140283A0 (en) 2002-02-10
CN1313951A (zh) 2001-09-19
CN1161615C (zh) 2004-08-11
EP1090300A1 (de) 2001-04-11
PL345318A1 (en) 2001-12-03
CA2335793A1 (en) 1999-12-29
NO20006545L (no) 2001-02-21
NO20006519L (no) 2001-02-21
AU760165B2 (en) 2003-05-08
NO20006519D0 (no) 2000-12-20
IL140394A0 (en) 2002-02-10
HRP20000888A2 (en) 2001-12-31
EP1088056A1 (de) 2001-04-04
CN1607391A (zh) 2005-04-20
RU2227916C2 (ru) 2004-04-27
TR200003830T2 (tr) 2002-01-21
WO1999067644A1 (en) 1999-12-29
AU4360599A (en) 2000-01-10

Similar Documents

Publication Publication Date Title
ATE269001T1 (de) Verfahren zur suspendierung von einschlusskörpern
ATE359358T1 (de) Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden
ATE420945T1 (de) Chemisch definiertes medium für kultivierte säugerzellen
SE8504872D0 (sv) Selekteringsforfarande och medel herfor
DE69939468D1 (de) Verfahren um den Erfolg von einem auf in-vitro Maturation (IVM) basierten Verfahren zu vorhersagen
DK0799058T3 (da) Forbedringer af eller med hensyn til endometriefunktion
DK1218489T3 (da) Pluripotente embryonlignende stamceller, præparater, fremgangsmåder og anvendelse deraf
ATE67787T1 (de) Verfahren zur herstellung von proteinen mittels induzierbarer expressionssysteme in in-vivovermehrten, genetisch modifizierten eukaryotischen wirtszellen.
Shabanowitz et al. Temporal appearance and cyclic behavior of Sertoli cell-specific secretory proteins during the development of the rat seminiferous tubule
DE69935221D1 (de) Methoden und medium zur in vitro-kultivierung von menschlichen embryos
Brunette et al. In-vitro cultural parameters and protein and prostaglandin secretion of epithelial cells derived from porcine rests of Malassez
DE3882725D1 (de) Verfahren zur trennung von boesartigen zellen aus einer klinischen probe.
DE69637154D1 (de) Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins
DE69838843D1 (de) Prenylcystein carboxyl methyl-transferase, dns, welche für selbige kodiert, und ein verfahren zur suche nach hemmstoffen
NO912621L (no) Fremgangsmaate for innfoering av dna i animalske celler.
Bump et al. A unique property of fetal bovine serum: high levels of protein-glutathione mixed disulfides
Garbarino et al. Identification of adenylate cyclase-coupled β-adrenergic receptors in the developing mammalian palate
ATE313622T1 (de) Verfahren zur züchtung von haftenden tierischen zellen
ATE299178T1 (de) Verfahren zur herstellung von säugetier-zellinien
DK439086A (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
Mallery et al. Cellular complexity of hemochorial placenta: stem cell populations, insights from scRNA-seq, and SARS-CoV-2 susceptibility
NZ515762A (en) Method of producing a heparin-binding protein by expressing it in a mammalian cell that can be cultured in anaerobic conditions
UY26907A1 (es) Proceso para preparar un factor inhibidor de neutrófilos
Freed et al. [78] Isolation and culture of haploid frog cells
JPS57186491A (en) Cultivation of fibroblast using fibronectin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition